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Case Presentation
J.G. and E.G. are 71-year-old monozygotic
twins. Both are retired painters who worked in
the Boston metropolitan area. The brothers
worked together but performed different, well-
deﬁned tasks: J.G. removed paint by scraping,
sanding, and heat treatment with an electric
iron; E.G. predominantly painted but at times
assisted in paint removal. J.G. smoked ciga-
rettes and ate at work without washing his
hands. E.G. smoked cigarettes until the early
1990s but reported that he was meticulous
about washing his hands before eating at work.
Both wore paper masks at work but did not use
any sophisticated respiratory protective devices.
In 1984, J.G. developed chronic back
pain, for which he was referred to a neuro-
surgeon. Because of his occupational history
of painting, a blood lead (BPb) level was
ordered and returned at 125 µg/dL. He was
subsequently hospitalized and chelated with
ethylenediamine tetra-acetic acid (EDTA).
Since his chelation he has been followed in the
Center for Occupational and Environmental
Medicine at what is now the Northeast
Specialty Hospital. J.G.’s other chronic health
problems include hypertension, which E.G.
has as well. Otherwise both brothers are
healthy. Both E.G. and J.G. graduated from
the same high school, served together in the
Navy, and have worked together as painters
for > 45 years. The combination of differential
lead exposures in the context of complete
genetic matching and similar childhood and
adult environments provided a unique oppor-
tunity for assessment of central nervous sys-
tem (CNS) effects of lead. Cognitive testing
and magnetic resonance spectroscopy (MRS)
studies were employed to determine differ-
ences that could be attributed to differential
lead exposures.
Neurocognitive testing. Both brothers were
tested on a battery of cognitive tests, including
the Wechsler Adult Intelligence Scale-Revised
(WAIS-R) (Wechsler 1981) and the Mini-
Mental State Exam (MMSE) (Folstein et al.
1975). A battery of speciﬁc tests designed to
assess the domains of attention, executive
function, verbal and language skills, visuospa-
tial abilities, manual motor speed and dexter-
ity, memory and behavior/personality was also
performed.
J.G. underwent cognitive testing in both
1990 and 1999. Based on his reported acade-
mic history and his performance on tests of
verbal and academic ability that are relatively
impervious to the effects of CNS insults in
adulthood, his premorbid verbal/language
abilities were judged to be at the lower end of
the average range and his visuospatial skills to
be at the upper end of the average range. In
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Seventy-one-year-old identical twin brothers with chronic lead poisoning were identiﬁed from an
occupational medicine clinic roster. Both were retired painters, but one brother (J.G.) primarily
removed paint and had a history of higher chronic lead exposure. Patella and tibia bone lead con-
centrations measured by K-X-ray ﬂuorescence in each brother were 5–10 times those of the general
population and about 2.5 times higher in J.G. than in his brother (E.G.). Magnetic resonance spec-
troscopy (MRS) studies examined N-acetylaspartate:creatine ratios, a marker of neuronal density.
Ratios were lower in J.G. than in his brother. Scores on neurocognitive tests that assess working
memory/executive function were below expectation in both twins. Short-term memory function
was dramatically worse in J.G. than in his brother. These results demonstrate some of the more
subtle long-term neurologic effects of chronic lead poisoning in adults. In particular, they suggest
the presence of frontal lobe dysfunction in both twins, but more dramatic hippocampal dysfunc-
tion in the brother with higher lead exposure. The MRS ﬁndings are consistent with the hypothe-
sis that chronic lead exposure caused neuronal loss, which may contribute to the impairment in
cognitive function. Although a causal relation cannot be inferred, the brothers were genetically
identical, with similar life experiences. Although these results are promising, further study is nec-
essary to determine whether MRS ﬁndings correlate both with markers of lead exposure and tests
of cognitive function. Nevertheless, the results point to the potential utility of MRS in determin-
ing mechanisms of neurotoxicity not only for lead but also for other neurotoxicants as well.
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tests, paint, twins. Environ Health Perspect 112:620–625 (2004). doi:10.1289/ehp.6687 available
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for estimated premorbid abilities in the
domains of manual motor skills, attention,
working memory/executive function, and
visuospatial abilities. Assessment of short-
term memory function showed deﬁcits at the
level of learning new information on several
tasks, but his retention of newly learned infor-
mation over delays was normal (i.e., he did
not show signiﬁcant forgetting of information
over delays). In 1999, J.G.’s performance was
within expected limits for estimated premor-
bid abilities in the domain of attention; how-
ever, he performed below expectation in the
domains of motor function, working mem-
ory/executive function, and visuospatial func-
tioning. On testing of short-term memory,
performance was below expectation at the lev-
els of both learning and retention of newly
learned information (i.e., he showed signifi-
cant forgetting). When comparing his 1999
performance with that in 1990, we used age-
adjusted outcome measures to control for the
age increase. His simple attention appeared to
improve. The most dramatic decline was seen
in the area of short-term memory, although
his manual motor control was also somewhat
worse. Scores on tasks assessing the domains
of working memory/executive function and
his drawings remained below expectation.
E.G. was tested only in 1999. Like his
brother, he consistently did better on visuo-
spatial than on verbal tasks, with verbal/
language skills at the lower end of the average
range and visuospatial skills at the upper end
of the average range. Test performance was
below expectation for estimated premorbid
abilities in the domains of motor skills, work-
ing memory/executive function, and visuo-
spatial abilities. On short-term memory tests,
he performed somewhat below expectation at
the level of learning on two tasks, but his
retention of newly learned information over
delays was normal.
A comparison of the 1999 assessments of
each twin showed that both had mild manual
motor deﬁcits, but these appeared to be more
pronounced in J.G. Scores on tests assessing
working memory/executive function were
likewise below expectation for both twins,
although on slightly different tasks. Short-
term memory function was dramatically
worse in J.G. than in E.G., involving both the
processes of learning and retention. The
neuropsychological test results are shown in
Table 1. Several test scores within each domain
were judged by the neuropsychologist to be
abnormal on the basis of estimated premorbid
skills for each brother. The cognitive test
results are consistent with frontal lobe dysfunc-
tion in both twins, but with rather dramatic
hippocampal dysfunction in J.G.
Bone lead levels and MRS. In 1998, bone
lead measurements were taken with a K-X-ray
ﬂuorescence (KXRF) bone lead analyzer (Aro
et al. 1994; Chettle et al. 1991). We deter-
mined the ratio of N-acetylaspartate (NAA) to
creatine, a marker of neuronal density, using
MRS. From each brother we obtained 1.5-tesla
single-voxel point resolved spectroscopy
(PRESS) spectra [repetition time ÷ echo time =
2,000/144 msec/msec with 128 averages] from
ﬁve voxels. The voxel locations were in the left
and right frontal lobes, the left and right hip-
pocampi, and one voxel in the left midbrain
encompassing the central semiovale and
selected from the same axial slice as the frontal
lobe voxels. Voxel sizes were roughly 1.7 cm3.
Spectral analysis was performed with software
supplied by the manufacturer (SA/GE; General
Electric Medical Systems, Milwaukee, WI) and
consisted of spectral phasing followed by peak
area fitting for the metabolite resonances of
choline, creatine, and NAA. Independent spec-
tral analyses were performed by two individuals
experienced with daily processing of clinical sin-
gle voxel spectra, and the results from each
region and operator were averaged. Examples of
spectra from the left frontal lobes of each twin
are shown in Figure 1. The bone lead concen-
trations and NAA:creatine ratios from the MRS
exams are summarized in Table 2. J.G. had
much higher levels of trabecular (patella) lead
and cortical (tibia) lead than did E.G. In gen-
eral, J.G. demonstrated a decrease of 10–30%
in the NAA:creatine ratio compared with E.G.
Discussion
The case of these twins illustrates many of
the classic clinical and public health issues
Environmental Medicine | MRS and lead poisoning
Environmental Health Perspectives • VOLUME 112 | NUMBER 5 | April 2004 621
Table 1. Neuropsychological testa results by functional domain.
J.G. E.G.
Tests organized by functional domain 1990 1999 1999
General intelligence
WAIS-R
Verbal IQb 94 98 93
Performance IQb 101 111 103
Fullscale IQb 96 103 96
MMSE 28/30 27/30 27/30
Wide Range Achievement Test–III
Readingb NA 94 104
Attention/executive function (expected = average)
WMS-R
Attention indexb 85c  95 96
Digit span forward 18th percentilec 46th percentile 46th percentile
Digit span backward 72nd percentile 66th percentile 66th percentile
Visual spans forward 1st percentilec 44th percentile 44th percentile
Visual spans backward 48th percentile 62nd percentile 62nd percentile
Mental control 6/6 4/6c 5/6
WAIS-R
Digit spans age-scaled scoresd 99 9
Arithmetic age-scaled scoresd 97 c 8
Trail-Making Test A 0 errors 0 errors 0 errors
Trail-Making Test B 3 errorsc 1 errors 2 errorsc
Continuous Performance Test NA 13 errorsc 19 errorsc
Verbal, language (expected = low average)
WAIS-R
Information age-scaled scoresd 10 12 12
Vocabulary age-scaled scoresd 89 9
Similarities age-scaled scored 10 8 8
Comprehensiond 10 13 9
Controlled word association 25–29th percentile 25–29th percentile < 10th percentilec
Boston Naming Test 40/60 43/60 50/60
Visuospatial/visual motor (expected = average)
Finger tapping test (avg no. taps in 5 trials of 10 sec each)
Right 74.2 (dom) 65.2 (dom) 58
Left 61.4 41.8c 53 (dom)
Grooved pegboard (seconds to place all pegs, avg of 2 trials)
Right NA 83 (dom) 83
Left NA 88 88 (dom)
WAIS-R
Picture completiond 91 1 1 0
Digit symbold 81 0 1 1
Picture arrangementd 11 11 12
Block designd 16 13 10
Object assemblyd 11 14 12
Boston Visuospatial Quantitative Battery drawings Impairedc Smallc Impairedc
Perseverativec Impairedc Perseverativec
Perseverativec
Rey-Osterrieth ﬁgure copy NA > 16th percentile 75–99th percentile
Continued, next pagesurrounding acute and chronic adult lead tox-
icity and offers a unique opportunity to
explore the utility of MRS for examining
effects of lead exposure. Although both twins
had elevated body burdens of lead, there were
differences between them, which, in identical
twins with very similar life exposures, pro-
vided an ideal opportunity to explore the use
of MRS technology for assessing the impact
of lead toxicity on the CNS and perhaps shed
light on mechanisms of action.
Lead exposure in Massachusetts.
Construction work has become the dominant
source of lead exposure for adults in the United
States. In Massachusetts, 1 of the 27 states that
currently maintain central registries of blood
lead tests and report surveillance data to the
National Institute for Occupational Health
and Safety and Health Adult Blood Lead
Epidemiology and Surveillance Program
[Centers for Disease Control and Prevention
(CDC) 1999], construction workers accounted
for 63% of 381 individuals identified with
BPb levels of ≥ 40 µg/dL—the action level
in the Occupational Health and Safety
Administration’s (OSHA) standard (Rabin
et al. 1994). Most houses in the United States
built before 1978 (estimated at 42–47 million
houses) have lead-based paint inside and out-
side [Agency for Toxic Substances and Disease
Registry (ATSDR) 1998]. Lead paint can con-
tain up to 50% lead by weight, which poses an
enormous risk to construction workers—
including painters—who remove it as well as
to children whose hand-to-mouth behavior
and frequent floor activity raise their risk of
ingesting lead paint chips and lead-contami-
nated house dust. Scraping, and, in particular,
sanding lead paint creates a ﬁne lead dust that
can be easily inhaled. Absorption of lead is
highly efﬁcient after inhalation, particularly if
the particles are small. Hand-to-mouth
behavior of construction workers can also lead
to significant absorption of lead, such as
smoking cigarettes and eating without prior
hand washing. Lead dust on the hands can be
ingested and absorbed through the gastro-
intestinal tract as can lead dust on cigarettes,
which can be heated during smoking generat-
ing lead fumes that are especially well
absorbed by the lungs. In addition to use in
residences, lead paint was also used in com-
mercial buildings and other structures, such as
bridges. Workers who remove paint in these
sectors are at extremely high risk for lead
exposure (Levin and Goldberg 2000).
Construction work is regulated under the
OSHA construction lead standard that took
effect in 1993 (OSHA 1993), and some states
have additional standards that apply specifi-
cally to the painting and deleading of resi-
dences. Such regulations require the use of
certain personal protective equipment (e.g.,
special respirators) and work techniques that
reduce exposure (e.g., “wet scraping” to
reduce dust), as well as prohibit certain activi-
ties that increase exposure (e.g., smoking and
eating at work). These regulations, however,
are often difﬁcult to enforce and do not apply
to individual homeowners who undertake
renovations themselves.
Neurocognitive effects of lead. Although
lead has adverse effects on numerous health
end points (ATSDR 1999), the most sensitive
target of lead exposure is the nervous system.
Neurologic functions for which there is evi-
dence of an adverse effect of chronic exposure
to lead include peripheral nerve conduction
velocity, postural balance, visual and auditory
evoked potentials, cardiac autonomic nervous
system function, and neurocognitive functions
mediated by the CNS (Araki et al. 2000;
Environmental Medicine | Weisskopf et al.
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Table 1. Continued
J.G. E.G.
Tests organized by functional domain 1990 1999 1999
Short-term memory (expected = average)
WMS-R indices
General memoryb 99 97 100
Verbal memoryb 93 93 89
Visual memoryb 111 107 115
Delayed recallb 111 90c 111
WMS-R
Orientation 14/14 14/14 NA
Logical memory
Immediate recall 44th percentile 28th percentile 24th percentile
Delayed recall 37th percentile 37th percentile 46th percentile
Paired associate learning
Immediate recall 15/24c 16/24c 16/24c
Delayed recall 8/8 5/8c 8/8
Difﬁcult paired associate learning
Immediate recall 13/40c 6/40c 4/40c
Delayed recall 5/40c 2/40c 2/40c
Consonant trigrams 31/60c NA NA
California Verbal Learning Test
Trials 1–5e NA –4c 0
Interference liste NA –1c 0
Short delay recalle NA –3c –1c
Short delay cued recalle NA –3c 0
Long delay free recalle NA –5c +1
Long delay cued recalle NA –5c 0
Recognitiond NA –5c +1
WMS-R
Figural memory 5/10c 6/10c 6/10c
Visual paired associate learning
Immediate recall 13/18c 12/18c 7/18c
Delayed recall 5/6 6/6 6/6
Visual reproduction
Immediate recall 98th percentile 52th percentile 98th percentile
Delayed recall 98th percentile 56th percentile 94th percentile
Mood/personality
Proﬁle of Mood States Confusionc Fatiguec WNL
Fatiguec
Minnesota Multiphasic Personality Inventory Normal Increase in WNL
proﬁle depression but WNL
Abbreviations: avg, average; dom, dominant hand; NA, not available; WMS-R, Wechsler Memory Scale–Revised; WNL,
within normal limits.
aSee Lezak (1998) and Spreen and Strauss (1998) for further details on individual tests. bMean ± SD, 100 ± 15. cBelow
expectation based on estimated premorbid abilities. dMean ± SD, 10 ± 3. eSDs below average.
3.0 2.5 2.0
Cho
Cr
NAA
3.0 2.5 2.0
Cho
Cr
NAA A B
Frequency (ppm) Frequency (ppm)
Figure 1. Spectra from the left frontal lobes of (A) J.G. and (B) E.G. Abbreviations: Cho, choline; Cr, creatine. Balbus-Kornfeld et al. 1995; Cheng et al.
1998). Acute lead exposure can lead to clinical
manifestations of lead poisoning in the adult,
including seizures, coma, and even death,
although BPb levels must be quite high
(ATSDR 1999); this has become rare in the
past 15–20 years. In children, such effects may
be seen at lower levels [e.g., > 70–80 µg/dL
(ATSDR 1999)]. Less severe neurologic and
behavioral effects have been documented in
lead-exposed workers with BPb levels between
40 and 120 µg/dL. Evidence consistently indi-
cates that lead-exposed workers perform worse
on tests of visual motor functioning, reaction
time, memory, attention, and concentration,
with effects on mood also often being noted
(Arnvig et al. 1980; Baker et al. 1984;
Campara et al. 1984; Grandjean et al. 1978;
Haenninen et al. 1978; Hogstedt et al. 1983;
Schwartz et al. 2001; Stollery 1996; Stollery
et al. 1991; Valciukas et al. 1978).
The association between low-level lead
exposure and neurocognitive function has
been most extensively studied in children,
particularly in relation to measures of IQ
(Banks et al. 1997; Needleman and Gatsonis
1990; Schwartz 1994). Although the current
BPb level of concern set forth by the CDC is
10 µg/dL, there may be no lower limit of BPb
level at which these effects occur (Canfield
et al. 2003; Schwartz 1994). Similar effects
may also occur in adults at levels well below
40 µg/dL, because impairments in neurocogni-
tive functioning in several domains have
recently been associated with very low BPb lev-
els (Muldoon et al. 1996; Payton et al. 1998).
However, this issue remains unresolved (Seeber
et al. 2002). The half-life of lead in blood is
only about 1 month, so BPb levels may reﬂect
only relatively recent exposure. To the extent
that bone lead acts as a source of lead in blood,
however, BPb can reﬂect longer-term exposure.
In a review of the evidence that cumulative
exposure to lead impairs cognitive function in
adults, Balbus-Kornfeld et al. (1995) con-
cluded that the evidence was not strong. The
authors acknowledged that their conclusions,
however, may possibly have more to do with
the availability of good measures of cumulative
exposure than a lack of a true association
(Balbus-Kornfeld et al. 1995). Since that time,
several other studies have assessed this associa-
tion. Three studies using multiple BPb mea-
surements to create an integrated measure of
cumulative exposure among occupationally
exposed populations reported cross-sectional
associations of this measure with lower neuro-
behavioral test scores (Chia et al. 1997;
Lindgren et al. 1996; Lucchini et al. 2000),
although one such study failed to ﬁnd an asso-
ciation with their cumulative lead measure
(Barth et al. 2002). Several other studies used
KXRF technology to assess cumulative lead
exposure (the half-life of lead in bone is
decades) and its association with cognitive per-
formance. Most of these studies were cross-
sectional in design and involved occupationally
exposed populations. One of these with a
small sample size (n = 57) did not ﬁnd a rela-
tion between bone lead and neurobehavioral
tests (Osterberg et al. 1997) and two others
found small effects of bone lead (Hanninen
et al. 1998; Schwartz et al. 2001), whereas the
others reported more robust associations
between higher bone lead and worse neuro-
cognitive performance (Bleecker et al. 1997;
Fiedler et al. 2003; Stewart et al. 1999). Two
other studies of an elderly general (nonoccu-
pational) population of men found that
higher bone lead was associated with impair-
ments on neuropsychological tests of visual
memory and spatial copying (Payton et al.
1998) and increased odds of scoring < 24 on
the MMSE—a traditional cut point for
increased risk of dementia (Wright et al.
2003). In addition, studies have suggested
that both the ApoE genotype and education
level interact with the cumulative effect of
lead on cognitive performance (Bleecker et al.
2002; Stewart et al. 2002). The only study to
examine longitudinal decline in cognitive
function found that higher tibia lead levels
predicted declines in verbal memory and
learning, visual memory, executive ability,
and manual dexterity among former lead
workers (Schwartz et al. 2000).
The pattern of cognitive deficits in the
twins that we report here is generally quite
typical of the pattern of deﬁcits reported after
high-level lead exposure. This pattern includes
predominant impairments in the domains of
attention/executive function, visuospatial/
visual motor functioning, short-term memory,
and (for J.G.) confusion and fatigue, whereas
verbal language and general intelligence remain
relatively unimpaired. Test of single-word
reading, basic written arithmetic, and semantic
knowledge (e.g., the ability to name common
objects) are not generally sensitive to exposure
to neurotoxicants in adults. Disruptions of
these types of cognitive functions are usually
seen only after widespread brain damage (e.g.,
frank hypoxia, severe traumatic brain injury,
Alzheimer disease after the initial stages) or
focal strokes involving highly specific brain
areas that mediate language and calculations.
For these reasons, neuropsychologists often use
these tests when evaluating adults with sus-
pected CNS insults to estimate premorbid pat-
terns and levels of cognitive function in
different domains (especially verbal, visuo-
spatial, and attention). After exposure to toxi-
cants such as lead in adulthood, cognitive
deﬁcits tend to be speciﬁc, not generalized and
not affecting language centers in the brain. In
the case of lead, this is probably due to its
action on hippocampal and frontal areas of the
brain. In a recent study of cumulative (bone
lead) exposure in a general population, Wright
et al. (2003) found a significant association
with slightly lower scores on the MMSE.
Overall, J.G. scored lower on the neuro-
cognitive testing than did his brother (E.G.),
which is consistent with J.G.’s higher bone
lead levels and lower NAA:creatine ratios. In
the case of the twins presented here, however,
we cannot distinguish what effects might be
related to high acute BPb concentrations as
opposed to cumulative exposure reflected in
the high bone lead levels. It should also be
noted that other known neurotoxicants such
as solvents are frequently used in painting.
Some of the functional deﬁcits noted in this
study may in part be related to toxicants other
than lead, and differential exposure to these
other neurotoxicants could also contribute to
some of the differences on cognitive tests
between the twins.
The magnetic resonance images (MRIs)
from the twins showed lesions indicative of
microinfarcts. This is consistent with known
adverse effects of lead on the cardiovascular sys-
tem. In the context of the neurobehavioral
deficits exhibited by the twins, it is possible
that these outcomes are to some extent the
result of adverse cerebrovascular events brought
about as the result of chronic lead exposure.
Such effects would constitute an indirect
action of lead on neuronal density and neuro-
behavioral impairment through actions on the
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Table 2. Summary of bone lead and BPb levels and NAA:creatine ratios.
J.G. E.G.
Bone lead
Patella, 1998 (µg/g bone)a 343 ± 9.4 119 ± 8.8
Tibia, 1998 (µg/g bone)a 189 ± 7.8 79 ± 7.2
BPb(µg/dL)
November 1989 88 33
October 1990 51 20
Fall 1994b 51 15
May 1998 30 ND
NAA:creatine ratioc
Hippocampus 1.30 ± 0.10 1.60 ± 0.20
Frontal lobe 1.15 ± 0.17 1.52 ± 0.48
Midbrain 1.47 ± 0.02 1.65 ± 0.02
ND, no data.
aMeasured value ± uncertainty. bNovember for J.G. and September for E.G. cMean ± SD.cerebrovascular system, in addition to the
likely direct effects on the nervous system.
MRS measurements of neuronal density.
The effects of elevated blood and bone lead
levels have been examined primarily in the
context of behavioral and neuropsychologic
evaluations. There has been a growing interest
in the mechanisms by which lead disrupts
brain function. Although the adverse effects
of lead exposure on neurobehavioral function-
ing is one of the most consistently reported
impairments associated with lead exposure,
little is known about the effects of lead on
brain metabolism in vivo or about the struc-
tural and functional correlates of lead-related
brain dysfunction.
MRS provides a noninvasive method with
which to monitor biochemical aspects of acute
and chronic stages of neurologic disease in the
human brain. The development of spatially
localized spectroscopic methods that sample
the relative levels of metabolites from volumes
of tissue deﬁned from MRI scans has provided
a basis for integrating the biochemical infor-
mation obtained by MRS with the anatomical
and pathological information obtained from
MRIs. MRS has gained widespread acceptance
as a method for assessing both neuronal viabil-
ity and demyelination. MRS can detect both
NAA and creatine in discrete tissue volumes.
In the cortex, NAA is located in neuronal cell
bodies, whereas in the white matter, it is
located largely in axons. A decrease in NAA
has been proposed as an indicator of neuronal
and axonal damage and loss (Arnold and De
Stefano 1997; van der Knaap et al. 1992). In
practice, the decrease in NAA is measured rel-
ative to the level of creatine, a stable metabo-
lite whose level is constant after neuronal loss.
The use of MRS to examine the effects of
lead exposure is new. A report on MRS ﬁnd-
ings in a 10-year-old boy with elevated BPb
levels and his 9-year-old male cousin who did
not have elevated BPb showed that the lead-
exposed boy had lower NAA:creatine ratios in
both frontal gray and white matter (Trope
et al. 1998). A subsequent study of 16 chil-
dren with elevated BPb levels and 5 children
whose measured BPb levels had never been
>1 0µ g/dL found that the children with ele-
vated BPb levels had statistically signiﬁcantly
lower NAA:creatine ratios in frontal gray mat-
ter. NAA:creatine ratios were also lower for
these children in frontal white matter, but this
did not reach statistical significance (Trope
et al. 2001). These results, as well as evidence
showing reduced NAA in disease processes
involving intellectual deterioration, led us to
hypothesize a decrease in NAA in the brains of
adults with clinical evidence of lead exposure.
In the twins presented here, J.G. had
NAA:creatine ratios that were lower than
those of E.G., suggesting lower neuronal den-
sity. This is consistent with the results of the
neurocognitive tests, on which J.G. performed
worse in general than did E.G. In addition,
J.G. demonstrated declines between 1990 and
1999 on tests assessing short-term memory and
visuospatial performance, suggesting a new
progressive process that may be related to his
history of lead exposure. Both twins, however,
showed significant impairments on several
neuropsychological tests, which is consistent
with the fact that they both had bone lead lev-
els that were high for their age, because both
patella and tibia lead levels are typically
<4 0µ g/g bone in community-exposed indi-
viduals around 71 years of age (Hu et al.
1996). This also may suggest that although
E.G.’s NAA:creatine ratios were higher than
those of J.G., the NAA:creatine ratios seen in
E.G. may be lower than expected for age-
matched non-lead–exposed individuals.
The NAA:creatine ratio has been reported
in a number of MRS studies of brain metabo-
lites in control populations and populations
with speciﬁc diseases such as amyotrophic lat-
eral sclerosis (ALS) and Alzheimer disease
(Barker et al. 2000; Chan et al. 1999;
Doraiswamy et al. 1998; Kreis et al. 1993;
Lundbom et al. 1999). It is important to note
that the NAA:creatine ratio has not only
regional (Barker et al. 2000; Jayasundar and
Raghunathan 1997; Kreis et al. 1993;
Lundbom et al. 1999; Ricci et al. 2000) and
developmental dependencies but also depends
on the speciﬁc echo time and repetition time
of the MRS pulse sequence used to acquire
the data as the relaxation times, T1 and T2,
because the different metabolites are not iden-
tical (Kreis et al. 1993). For instance, Chan
et al. (1999) reported NAA:creatine ratios in
the motor cortex of 3.08 ± 0.32 for 14
healthy subjects (mean age, 57 ± 11 years)
compared with 2.40 ± 0.42 for 11 patients
with ALS. Lundbom et al. (1999) studied the
NAA:creatine ratio in the context of the nor-
mal aging process and reported NAA:creatine
ratios from 1.88 to 2.59 for ﬁve elderly volun-
teers (mean age, 74 ± 7) compared with 2.07
to 3.54 for seven younger volunteers (mean
age 35 ± 6 years). Barker et al. (2000) meas-
ured NAA:creatine in six healthy volunteers
(mean age, 38±3years) and reported values
ranging from 1.75 to 3.03 depending on the
brain region examined. In these three studies,
repetition time values identical or comparable
with our value of 2,000 msec were used.
However, these studies used longer echo time
values of 272 to 280 msec compared with the
144 msec used in the present study. Thus, to
compare ratios, correction factors accounting
for the differential T2 decay must be applied.
Assuming a mixture of gray and white matter,
representative NAA and creatine T2 values
may be estimated from the study of Kreis et
al. (1993) to be 441 msec and 207 msec,
respectively. Thus, to compare NAA:creatine
ratios from the studies mentioned above with
our NAA:creatine ratios, a correction factor of
approximately 0.72 must be applied. Taking
the range reported by Lundbom et al. (1999)
of 1.88 to 2.59 for elderly volunteers, we
would expect a range of 1.35 to 1.86 for the
NAA:creatine ratios at the 144-msec echo
time used in our study. The range of
NAA:creatine values we found in the two
elderly brothers in our study were from 1.15
to 1.89, within the range if somewhat lower
than what may be anticipated from normal
elderly volunteers. It is important to note that
the average NAA:creatine values of 1.31 ±
0.16 and of 1.59 ± 0.07 for J.G. and E.G.,
respectively, fall within the range anticipated
from the control values estimated above.
Furthermore, these values are within the
range of NAA:creatine values measured by
Doraiswamy et al. (1998), who used MRS
sequence parameters directly comparable with
ours in their study of 12 elderly (mean age,
73 ± 9 years) probable Alzheimer patients.
J.G. presents a mean NAA:creatine value sim-
ilar to the lowest value reported in that study.
Clearly, as the field of MRS matures and
NAA:creatine ratios for larger control popula-
tions at various ages are measured, more
meaningful interpretations of NAA:creatine
values in given individuals may be made.
Within the context of the present study,
although there may not be an exact relation
between the NAA:creatine ratios we obtained
in the twin brothers and those found in other
studies, the difference in NAA:creatine ratio
between the twins spans a range on the order
of that seen for elderly adults in other studies.
Although we cannot conclusively attribute
the differences in NAA:creatine ratios between
the brothers to the differences in lead exposure,
the fact that these two brothers matched for
genetics, education level, and many life experi-
ences would support the hypothesis that the
lower NAA:creatine ratios in J.G. are second-
ary to higher lead exposure. If so, this suggests
that chronic lead exposure caused a loss of neu-
rons in the hippocampus, frontal cortex, and
midbrain. Possible mechanisms of cell loss
include lead-induced oxidative toxicity
(Adonaylo and Oteiza 1999), cellular apoptosis
without necrosis (Fox et al. 1998), and indirect
oxidative toxicity via increases in the metabo-
lite aminolevulinic acid (Bechara 1996).
Clearly the study of the relation between lead
exposure and neuronal density as assessed by
MRS in a larger population will be necessary to
determine these relations with more certainty.
Conclusions
Construction work has become the dominant
source of lead exposure in U.S. adults.
Neurobehavioral sequelae of lead toxicity are
not uncommon and studies are beginning to
suggest that these outcomes can occur with
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rent U.S. regulation. Presenting symptoms of
acute lead toxicity are often vague and may
likely involve health end points other than
neurobehavioral ones, such as the back pain
that initially brought J.G.’s lead exposure to
medical attention. Thus, particularly when
dealing with construction workers, a high
index of suspicion and a low threshold for
testing BPb levels are called for in order to
diagnose lead toxicity.
In the cases presented, both of the mono-
zygotic twin painters clearly had extremely
high bone lead levels. Nonetheless, their dif-
ferential lead exposure resulting from different
job tasks was reﬂected in differences in bone
lead levels. On the background of genetic
identity and extremely similar life exposures,
the relations between lead levels, neuro-
psychological testing, and MRS results are
highly suggestive. The markedly higher bone
lead levels in J.G. were paralleled by greater
deficits in neuropsychological testing perfor-
mance and lower NAA:creatine ratios in the
hippocampus and frontal lobes. These results
are consistent with neuronal loss secondary to
lead exposure, which could be responsible in
part for the impaired neuropsychological
function on hippocampal and frontal-lobe–
dependent tasks. Although we cannot estab-
lish cause and effect, we believe that MRS
may be a valuable research tool in determin-
ing the mechanisms of neurotoxicity of lead
and potentially other neurotoxicants as well.
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